AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2024

Nov 25, 2024

30071_dirs_2024-11-25_5ad8a36d-948b-4c5b-b930-74bdd77e2a9c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2024-11-22

Reporting Person: Leong Justin (Chief Product Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-11-22	ReMed Common Stock	S	6160	$243.087	Disposed	21718	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $243.00 - $243.315. The price reported above reflects the weighted average sale price.